Solid lipid nanoparticles :A promising tool for drug delivery system

Basu, Biswajit; Garala, Kevin; Bhalodia, Ravi; Joshi, Bhavik; Mehta, Kuldeep

dc.contributor.author	Basu, Biswajit
dc.contributor.author	Garala, Kevin
dc.contributor.author	Bhalodia, Ravi
dc.contributor.author	Joshi, Bhavik
dc.contributor.author	Mehta, Kuldeep
dc.date.accessioned	2023-05-27T06:15:14Z
dc.date.available	2023-05-27T06:15:14Z
dc.date.issued	2010
dc.identifier.citation	Biswajit Basu, Kevin Garala, Ravi Bhalodia, Bhavik Joshi, Kuldeep Mehta. (2010). Biswajit Basu et al. / Journal of Pharmacy Research 2010, 3(1),84-92, ISSN: 0974-6943	en_US
dc.identifier.issn	0974-6943
dc.identifier.uri	http://10.9.150.37:8080/dspace//handle/atmiyauni/1132
dc.description.abstract	Solid lipid nanoparticles (SLNs) technology represents a promising new approach to lipophilic drug delivery. Solid lipid nanoparticles are important advancement in this area. The biodegradable and bioacceptable nature of SLNs makes them less toxic as compared to polymeric nanoparticles. SLNs can also be used to improve the bioavalability of drugs. In this present review this new approach is discussed in terms of their advantages, characterization, in-vivo studies, in-vitro studies, pharmacokinetic studies and special features.	en_US
dc.language.iso	en	en_US
dc.publisher	Journal of Pharmacy Research	en_US
dc.subject	Solid lipid nanoparticles	en_US
dc.subject	in-vivo studies	en_US
dc.subject	in-vitro studies	en_US
dc.title	Solid lipid nanoparticles :A promising tool for drug delivery system	en_US
dc.type	Article	en_US